These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26739950)

  • 41. Controversies on the role of 5-HT(2C) receptors in the mechanisms of action of antidepressant drugs.
    Martin CB; Hamon M; Lanfumey L; Mongeau R
    Neurosci Biobehav Rev; 2014 May; 42():208-23. PubMed ID: 24631644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
    De Deurwaerdère P; Navailles S; Berg KA; Clarke WP; Spampinato U
    J Neurosci; 2004 Mar; 24(13):3235-41. PubMed ID: 15056702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide.
    Dracheva S; Patel N; Woo DA; Marcus SM; Siever LJ; Haroutunian V
    Mol Psychiatry; 2008 Nov; 13(11):1001-10. PubMed ID: 17848916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin and drug reward: focus on 5-HT2C receptors.
    Higgins GA; Fletcher PJ
    Eur J Pharmacol; 2003 Nov; 480(1-3):151-62. PubMed ID: 14623358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serotonin/dopamine interaction--focus on 5-HT2C receptor, a new target of psychotropic drugs.
    Di Giovanni G; Di Matteo V; Esposito E
    Indian J Exp Biol; 2002 Dec; 40(12):1344-52. PubMed ID: 12974395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
    Reynolds GP; Templeman LA; Zhang ZJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-HT(2C) receptor RNA editing in the amygdala of C57BL/6J, DBA/2J, and BALB/cJ mice.
    Hackler EA; Airey DC; Shannon CC; Sodhi MS; Sanders-Bush E
    Neurosci Res; 2006 May; 55(1):96-104. PubMed ID: 16580757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A-to-I pre-mRNA editing of the serotonin 2C receptor: comparisons among inbred mouse strains.
    Du Y; Davisson MT; Kafadar K; Gardiner K
    Gene; 2006 Nov; 382():39-46. PubMed ID: 16904273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gene expression in mental diseases--from DNA to RNA].
    Kato T; Iwamoto K
    Seishin Shinkeigaku Zasshi; 2004; 106(1):49-52. PubMed ID: 15152655
    [No Abstract]   [Full Text] [Related]  

  • 50. Altered serotonin 2C receptor RNA splicing in suicide: association with editing.
    Dracheva S; Chin B; Haroutunian V
    Neuroreport; 2008 Feb; 19(3):379-82. PubMed ID: 18303585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotonin 2C receptor as a superhero: diversities and talents in the RNA universe for editing, variant, small RNA and other expected functional RNAs.
    Tohda M
    J Pharmacol Sci; 2014; 126(4):321-8. PubMed ID: 25427431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonin1A autoreceptor activation by S 15535 enhances circadian activity rhythms in hamsters: evaluation of potential interactions with serotonin2A and serotonin2C receptors.
    Gannon RL; Millan MJ
    Neuroscience; 2006; 137(1):287-99. PubMed ID: 16289351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutagenesis Analysis Reveals Distinct Amino Acids of the Human Serotonin 5-HT
    Liu Y; Canal CE; Cordova-Sintjago TC; Zhu W; Booth RG
    ACS Chem Neurosci; 2017 Jan; 8(1):28-39. PubMed ID: 27580242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and characterization of RNA editing events within the 5-HT2C receptor.
    Niswender CM; Sanders-Bush E; Emeson RB
    Ann N Y Acad Sci; 1998 Dec; 861():38-48. PubMed ID: 9928237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RNA splicing and editing modulation of 5-HT(2C) receptor function: relevance to anxiety and aggression in VGV mice.
    Martin CB; Ramond F; Farrington DT; Aguiar AS; Chevarin C; Berthiau AS; Caussanel S; Lanfumey L; Herrick-Davis K; Hamon M; Madjar JJ; Mongeau R
    Mol Psychiatry; 2013 Jun; 18(6):656-65. PubMed ID: 23247076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No link of serotonin 2C receptor editing to serotonin transporter genotype.
    Lyddon R; Cuppen E; Haroutunian V; Siever LJ; Dracheva S
    Neuroreport; 2010 Dec; 21(17):1080-4. PubMed ID: 20948451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-HT
    Ji G; Zhang W; Mahimainathan L; Narasimhan M; Kiritoshi T; Fan X; Wang J; Green TA; Neugebauer V
    J Neurosci; 2017 Feb; 37(6):1378-1393. PubMed ID: 28011743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders.
    Wood MD
    Curr Drug Targets CNS Neurol Disord; 2003 Dec; 2(6):383-7. PubMed ID: 14683466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonin2C receptor mRNA editing in neuropathic pain model.
    Nakae A; Nakai K; Tanaka T; Takashina M; Hagihira S; Shibata M; Ueda K; Mashimo T
    Neurosci Res; 2008 Feb; 60(2):228-31. PubMed ID: 18045717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Htr2c Splice Variants and 5HT
    Isles AR
    Trends Endocrinol Metab; 2017 Aug; 28(8):542-544. PubMed ID: 28499663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.